BACKGROUND: Changes in the use of psychoactive substances and medications and in the occurrence of substance-related disorders enable assessment of the magni- tude of the anticipated negative consequences for the population. METHODS: Trends were analyzed in the consumption of tobacco, alcohol, cannabis and other illegal drugs, analgesics, and hypnotics/sedatives, as well as trends in substance-related disorders, as coded according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). The data were derived from nine waves of the German Epidemiological Survey of Substance Abuse (Epidemiologischer Sucht- survey, ESA) from 1995 to 2018. The data were collected in written form or by means of a combination of paper and internet-based questionnaires or telephone interviews. RESULTS: The estimated prevalence rates of tobacco and alcohol consumption and the use of hypnotics/sedatives decreased over time. On the other hand, increasing prevalence rates were observed for the consumption of cannabis and other illegal drugs and the use of analgesics. The trends in substance-related disorders showed no statistically significant changes compared to the reference values for the year 2018, except for higher prevalence rates of nicotine dependence, alcohol abuse and dependence, analgesic dependence, and hypnotic/sedative dependence in the year 2012 only. CONCLUSION: Trends in tobacco and alcohol consumption imply a future decline in the burden to society from the morbidity, mortality, and economic costs related to these substances. An opposite development in cannabis use cannot be excluded. No increase over time was seen in the prevalence of analgesic dependence, but the observed increase in the use of analgesics demands critical attention.
BACKGROUND: Changes in the use of psychoactive substances and medications and in the occurrence of substance-related disorders enable assessment of the magni- tude of the anticipated negative consequences for the population. METHODS: Trends were analyzed in the consumption of tobacco, alcohol, cannabis and other illegal drugs, analgesics, and hypnotics/sedatives, as well as trends in substance-related disorders, as coded according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). The data were derived from nine waves of the German Epidemiological Survey of Substance Abuse (Epidemiologischer Sucht- survey, ESA) from 1995 to 2018. The data were collected in written form or by means of a combination of paper and internet-based questionnaires or telephone interviews. RESULTS: The estimated prevalence rates of tobacco and alcohol consumption and the use of hypnotics/sedatives decreased over time. On the other hand, increasing prevalence rates were observed for the consumption of cannabis and other illegal drugs and the use of analgesics. The trends in substance-related disorders showed no statistically significant changes compared to the reference values for the year 2018, except for higher prevalence rates of nicotine dependence, alcohol abuse and dependence, analgesic dependence, and hypnotic/sedative dependence in the year 2012 only. CONCLUSION: Trends in tobacco and alcohol consumption imply a future decline in the burden to society from the morbidity, mortality, and economic costs related to these substances. An opposite development in cannabis use cannot be excluded. No increase over time was seen in the prevalence of analgesic dependence, but the observed increase in the use of analgesics demands critical attention.
Authors: Wilson M Compton; Beth Han; Christopher M Jones; Carlos Blanco; Arthur Hughes Journal: Lancet Psychiatry Date: 2016-08-31 Impact factor: 27.083
Authors: Margaretha de Looze; Quinten Raaijmakers; Tom Ter Bogt; Pernille Bendtsen; Tilda Farhat; Mafalda Ferreira; Emmanuelle Godeau; Emmanuel Kuntsche; Michal Molcho; Timo-Kolja Pförtner; Bruce Simons-Morton; Alessio Vieno; Wilma Vollebergh; William Pickett Journal: Eur J Public Health Date: 2015-04 Impact factor: 3.367
Authors: G Lachner; H U Wittchen; A Perkonigg; A Holly; P Schuster; U Wunderlich; D Türk; E Garczynski; H Pfister Journal: Eur Addict Res Date: 1998-03 Impact factor: 3.015
Authors: Amy Peacock; Janni Leung; Sarah Larney; Samantha Colledge; Matthew Hickman; Jürgen Rehm; Gary A Giovino; Robert West; Wayne Hall; Paul Griffiths; Robert Ali; Linda Gowing; John Marsden; Alize J Ferrari; Jason Grebely; Michael Farrell; Louisa Degenhardt Journal: Addiction Date: 2018-06-04 Impact factor: 6.526
Authors: Ludwig Kraus; Johanna K Loy; Nicolas Wilms; Anne Starker Journal: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz Date: 2021-05-12 Impact factor: 1.513
Authors: Udo Bonnet; Michael Specka; Michael Soyka; Thomas Alberti; Stefan Bender; Torsten Grigoleit; Leopold Hermle; Jörg Hilger; Thomas Hillemacher; Thomas Kuhlmann; Jens Kuhn; Christian Luckhaus; Christel Lüdecke; Jens Reimer; Udo Schneider; Welf Schroeder; Markus Stuppe; Gerhard A Wiesbeck; Norbert Wodarz; Heath McAnally; Norbert Scherbaum Journal: Front Psychiatry Date: 2020-10-26 Impact factor: 4.157